IMNM FY 2019 Earnings — Immunome, Inc. Revenue & Financial Results | Market Cap Arena

IMNMImmunome, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$615,000

Operating Income

-$10M

Net Income

-$11M

EPS (Diluted)

$-1.84

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$14,000

Balance Sheet

Total Assets

$5M

Total Liabilities

$41M

Stockholders' Equity

-$36M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$615,000	-$521,000	-18.0%
Operating Income	-$10M	-$8M	-33.6%
Net Income	-$11M	-$8M	-34.5%